This slide deck summarises the latest evidence supporting an association between hypertriglyceridaemia and atherosclerotic cardiovascular disease even when LDL-cholesterol is well controlled, and considers the potential of triglycerides and triglyceride-rich lipoprotein remnants as targets for future therapies to reduce residual cardiovascular risk and acute pancreatitis.
![](https://www.triglycerideforum.org/wp-content/uploads/2020/12/Residual-risk-v5.jpg)